• Journal of Chest Surgery
• /
• 제28권6호
• /
• pp.610-618
• /
• 1995

Three neonates with interrupted aortic arch with VSD underwent one stage repair using revised technique of cardiopulmonary bypass with short period of circulatory arrest. A left posterolateral thoracotomy was made to permit mobilization of the descending aorta and placement of polytetrafluoroethylene[PTFE graft for distal aortic perfusion. Then the patient was placed in the supine position and a median sternotomy was performed to permit the proximal dissection, VSD repair, and direct anastomosis between the ascending aorta and descending aorta. This technique has advantages to facilitate direct anastomosis between the ascending aorta and the descending aorta, to lessen circulatory arrest time, and to prevent dangerous laceration and post-operative narrowing of the thin small ascending aorta at cannulation site. There was no operative mortality but postoperative stenosis developed in one case which was relieved with balloon aortoplasty.

• Bulletin of the Korean Chemical Society
• /
• 제34권6호
• /
• pp.1663-1667
• /
• 2013

Neointimal hyperplasia causes vascular access dysfunction in hemodialysis patients with synthetic arteriovenous (AV) grafts. Several studies have reported that paclitaxel- or sirolimus-eluting AV grafts inhibit neointimal hyperplasia and display lower rates of stenosis compared with control grafts. However, there have been few comparative studies of the efficacy of paclitaxel- and sirolimus-eluting grafts. We compared the neointimal hyperplasia of paclitaxel- and sirolimus-eluting grafts. AV grafts were implanted laterally between the common carotid artery and the external jugular vein in 12 female Landrace pigs. The animals were sacrificed six weeks after surgery. The neointimal hyperplasia at the anastomosis sites of the grafts was quantified using the ratio of the intragraft hyperplasia to the graft area (H/G ratio) at the graft-vessel interface. The area of intimal hyperplasia at the venous (paclitaxel 1.06 [0.72-1.56] vs sirolimus 2.40 [1.72-3.0] $mm^2$, P = 0.04) and arterial anastomosis sites (paclitaxel 0.93 [0.57-1.48] vs sirolimus 2.40 [1.72-3.0] $mm^2$, P = 0.04) was significantly different between the two groups. However, the H/G ratios for the venous anastomosis site (paclitaxel 0.25 (0.17-0.38) vs sirolimus 0.38 (0.2-0.66), P = 0.4) and the arterial anastomosis site (paclitaxel 0.19 (0.08-0.39) vs sirolimus 0.41 (0.34-0.50), P = 0.1) did not differ significantly between the groups. In conclusion, there was no significant difference in the inhibition of neointimal hyperplasia by sirolimus- and paclitaxel-eluting AV grafts.

• Journal of Chest Surgery
• /
• 제28권8호
• /
• pp.754-758
• /
• 1995

Between February 1987 and April 1994,30 modified Blalock- Taussing shunts[MBTS were carried out at the Department of Thoracic and Cardiovascular Surgery of the Keimyung University Dongsan Medical Center.The operation consists of interposing between the subclavian artery and the pulmonary artery a polytetrafluoroethylene graft.There were 19 boys and 11 girls.The average age at the time of shunt construction was 14 months [range 4 days to 5 years .Seventy-six percent [23/30 were less than 1 year of age.Cardiac defects treated with MBTS included tetralogy of Fallot[10 , pulmonary atresia with ventricular septal defect[8 , pulmonary atresia with intact ventricular septum[4 , uni-ventricular heart[3 , and other complex cardiac anomalies[5 .Prosthesis of 4mm were used in 13 cases, and 5mm in 17.Of the 30 operations, 21 were performed on the right side and 9 on the left side.The hemoglobin level decreased from 21.1 gm/dl preoperatively to 16.3 gm/dl postoperatively and systemic oxygen saturation level increased from 60.5 % preoperatively to 85.4 % postoperatively.In the 30 patients who recieved MBTS, there were one early [3% and three late deaths [10% .Seven patients have had an corrective operation and two patient required second palliative procedure.The remaining patients are awaiting further operation with ingestion of aspirin [5 mg/kg/day as an antiplatelet agent.These results indicate that the MBTS provide excellent palliation at a low operative mortality for most patients.

• Journal of Chest Surgery
• /
• 제20권2호
• /
• pp.404-410
• /
• 1987

An 18-day-old male neonate with hypoplastic left heart syndrome underwent surgical intervention by modification of the Norwood procedure on September 23, 1986. Hypoplastic left heart syndrome is a serious congenital cardiac anomaly that has a fatal outlook if left untreated. Included in this anomaly are [1] aortic valve atresia, and hypoplasia of the ascending aorta and aortic arch, [1] mitral valve atresia or hypoplasia, and [3] diminutive or absent left ventricle. Patent ductus arteriosus is essential for any survival, and there is usually a patent foramen ovale. Coarctation of the aorta is frequently associated with the lesion.z With a limited period of cardiopulmonary bypass, deep hypothermia, and circulatory arrest, the ductus arteriosus was excised. The main pulmonary artery was divided immediately below its branches, and the distal stump of the divided pulmonary artery was closed with a pericardial patch. The aortic arch was incised, and a 1 5mm tubular Dacron prosthesis was inserted between the main pulmonary artery and the aortic arch. A 4mm shunt of polytetrafluoroethylene graft was established between the new ascending aorta and the right pulmonary artery to provide controlled pulmonary blood flow. Following rewarming, the heart started to beat regularly, but the patient could not be weaned from cardiopulmonary bypass. At autopsy, the patient was found to have hypoplasia of the aortic tract complex with mitral atresia and aortic atresia. A secundum atrial septal defect was noted. Right atrial and ventricular hypertrophy was present, and the left ventricle was entirely absent. Although unsuccessful in this case report, continuing experience with hypoplastic left heart syndrome will lead to an improvement in result.

• Journal of Chest Surgery
• /
• 제45권5호
• /
• pp.330-333
• /
• 2012

Aortoenteric fistula is a rare but potentially fatal condition causing massive gastrointestinal bleeding. In particular, double primary aortoenteric fistulae are vanishingly rare. We encountered a 75-year-old male patient suffering from abdominal pain, hematochezia, hematemesis, and hypotension. His computed tomography images showed abdominal aortic aneurysm and suspected aortoenteric fistulae. During surgery, we found two primary aortoenteric fistulae. The one fistula was detected between the abdominal aorta and the third portion of the duodenum, and the other fistula was detected between the abdominal aorta and the sigmoid colon. We conducted the closure of the fistulae, the exclusion of the aneurysm, and axillo-bifemoral bypass with a polytetrafluoroethylene graft. The patient was discharged with no complications on the 21st postoperative day.

• 한국간담췌외과학회지
• /
• 제27권4호
• /
• pp.423-426
• /
• 2023

Backgrounds/Aims: Patients who undergo pancreatic surgery with venous resection have high rates of morbidity/mortality. Also, they are high-risk for postoperative venous thromboembolism. Whether this group should be routinely anticoagulated is unknown. This study aimed to establish current anticoagulation practices. Methods: A survey (https://form.jotform.com/220242489107048) was sent out to pancreatic surgeons. Questions covered center volume, venous resection/reconstruction techniques and anticoagulation policies. Results: Sixty-five centers from 17 countries responded. Following a "side-bite" venous resection with a patch repair, 40% used an autologous vein patch, 27% used peritoneum, and 27% used a bovine patch. After formally resecting a segment of vein, 17% of centers used an interposition graft (IG). Left renal vein (41%) and polytetrafluoroethylene (73%) grafts were the most commonly used autologous and prosthetic IGs, respectively. Following a prosthetic IG, an autologous IG, and a "side-bite" resection, 59%, 28%, and 19% of centers provided therapeutic anticoagulation, respectively (66% used low molecular-weight heparin). The duration of therapy provided varied from inpatient stay only (14%) to six months (32%). Conclusions: Our global survey indicates that anticoagulation practices are highly variable. Centers do not agree on when to anticoagulate, how to anticoagulate, or the duration of therapy. A robust trial is required to provide clarity.

• Journal of Chest Surgery
• /
• 제38권3호
• /
• pp.241-244
• /
• 2005

57세 남자가 3년 전부터 발생한 좌측 팔의 통증과 감각이상을 주소로 내원하였다. 환자는 경미한 연하곤란을 호소하는 것 이외에 다른 증상은 얼었다. 좌측 팔의 동맥압은 촉지되지 않았으며, 흉부방사선 사진상 우측 대동맥궁이 의심되었다. 대동맥 조영술 상에서 우측 대동맥궁과 Kommerell 게실이 관찰되었고 좌쇄골하 동맥은 기시부의 완전 폐색을 보였으며 혈류는 척추 혈관을 통해 우회하여 쇄골하동맥에 공급되고 있었다. 전신마취 하에 우측 쇄골하 동맥으로부터 8 m 인조혈관을 이용하여 좌쇄골하 동맥에 연결하였다. Kommerell 게실은 크기가 작아 추적 관찰하기로 하였다.

• Journal of Periodontal and Implant Science
• /
• 제35권2호
• /
• pp.491-510
• /
• 2005

This study was performed to evaluate the effect of inorganic polyphosphate on bone formation in the calvaria of rabbit in the procedure of guided bone regeneration with bovine cancellous bone graft and titanium reinforced expanded polytetrafluoroethylene(TR-ePTFE) membrane. The rabbits were divided into four groups. Control group I used only TR-ePTFE membrane, control group II used TR-ePTFE membrane and deproteinized bovine bone mineral soaked in saline, experimental group III and IV used TR-ePTFE membrane and deproteinized bovine bone mineral soaked in 1% or 2% inorganic polyphosphate respectively. After decortication in the calvaria, GBR procedure was performed on 12 rabbits with titanium reinforced ePTFE membrane filled with deproteinized bovine bone mineral soaked in saline or inorganic polyphosphate. The animals were sacrificed at 2 weeks, 4 weeks, and 8 weeks after the surgery. Decalcified and non-decalcified specimens were processed for histologic and immunohistochemistric analysis. 1. Titanium reinforced ePTFE(TR-ePTFE) membrane showed good spacemaking and cell occlusiveness capability, but it showed poor wound stabilization. 2. The deproteinized bovine bone mineral did not promote bone regeneration, but it acted as a space filler. 3. There was no complete resorption of the deproteinized bovine bone mineral within 8 weeks. 4. 1% inorganic polyphosphate did not promote bone formation, but 2% inorganic polyphosphate promoted bone formation. Within the above results, 2% inorganic polyphosphate could be used effectively for bone regeneration.

• Journal of Korean Neurosurgical Society
• /
• 제62권6호
• /
• pp.635-642
• /
• 2019

Objective : The aim of this study was to investigate the biomechanical differences between human dura mater and dura mater substitutes to optimize biomimetic materials. Methods : Four groups were investigated. Group I used cranial dura mater (n=10), group II used $Gore-Tex^{(R)}$ Expanded Cardiovascular Patch (W.L. Gore & Associates Inc., Flagstaff, AZ, USA) (n=6), group III used $Durepair^{(R)}$ (Medtronic Inc., Goleta, CA, USA) (n=6), and group IV used $Tutopatch^{(R)}$ (Tutogen Medical GmbH, Neunkirchen am Brand, Germany) (n=6). We used an axial compression machine to measure maximum tensile strength. Results : The mean tensile strengths were $7.01{\pm}0.77MPa$ for group I, $22.03{\pm}0.60MPa$ for group II, $19.59{\pm}0.65MPa$ for group III, and $3.51{\pm}0.63MPa$ for group IV. The materials in groups II and III were stronger than those in group I. However, the materials in group IV were weaker than those in group I. Conclusion : An important dura mater graft property is biomechanical similarity to cranial human dura mater. This biomechanical study contributed to the future development of artificial dura mater substitutes with biomechanical properties similar to those of human dura mater.

• Journal of Chest Surgery
• /
• 제41권5호
• /
• pp.610-618
• /
• 2008

배경: 동맥경화성 하지 동맥 폐색증의 치료는 보존적 운동 요법, 약물 요법, 수술 방법 등으로 증상의 완화 및 혈류 개선을 기대할 수 있는데 그 중 동맥간 우회로 수술이 가장 효과적이라고 알려져 있다. 본 연구는 본원에서 시행한 우회로 수술의 단기 추적 결과를 조사하여 그 효과를 평가하고 개존율에 영향을 미치는 인자를 분석하여 향후 치료의 지표로 삼고자 한다. 대상 및 방법: 2002년 6월에서 2006년 4월까지 본원 흉부외과에서 동맥경화성 하지 동맥 폐색증으로 진단받고 동맥간 우회로 수술을 받았던 환자 96명을 대상으로 하였다. 증상과 Ankle-brachial index (ABI)의 변화를 통해 우회로 수술의 효용성을 파악하고 수술 후 합병증, 하지 절단율 그리고 이식편 개존율 등을 통해 단기 결과를 확인하였다. 성별, 연령, 흡연 유무, 동반 질환, 문합 위치, 이식편의 크기와 종류 등의 항목으로 개존율에 미치는 위험인자를 확인하였다. 이외에 폐색 부위, 약 복용 등을 각 의무기록을 바탕으로 후향적으로 조사하였다. 전체 평균 추적 기간은 $29.4{\pm}13.1$개월이었다. 결과: 대상 환자들의 평균 연령은 $65.95{\pm}9.61$세로 남성이 88예였으며 허혈성 하지 통증이 가장 많은 증상이었다. 동반 질환으로는 고혈압(61%), 당뇨병(42%), 심장 질환(35%) 순이었고 흡연자는 88명(91.7%)이었다 동맥 폐색 부위 중 가장 많은 부위는 표재성 대퇴동맥으로 44예(40%) 이었다. 수술 방법 중 이식편으로 Polytetra-fluoroethylene (PTFE) 인조 혈관을 이용한 대퇴-슬와동맥간 우회로술을 가장 많이 시행하였으며 대복재정맥도 11예에서 사용하였다. ABI는 수술 전 $0.30{\pm}0.11$에서 수술 후 $0.63{\pm}0.11$으로 의미 있는 증가를 보였다(p<0.001). 수술 후 1년, 3년 이식편 개존율은 각각 86.4%, 68.0%이었다. 개존 실패를 보인 경우는 29예(30.21%)였으며 남성, 흡연 그리고 고혈압이 동반되어 있는 경우가 실패군에서 유의하게 높았고 이 중 고혈압이 위험인자로 유의한 결과를 보였다(p=0.042). 결론: 동맥경화성 하지 동맥 폐색증의 동맥간 우회로 수술은 하지 통증, 파행증의 호전과 하지 절단을 예방하는데 비교적 효과적인 치료 방법이다. 장기적인 이식편 개존율을 유지하기 위해서는 남성 흡연자의 금연을 적극 유도하고 고혈압 환자의 철저한 혈압 조절이 동반됨과 동시에 수술시 적절한 이식편의 선택, 규칙적인 약물 복용, 꾸준한 외래 추적관찰 등의 효과적인 관리가 필요할 것으로 사료된다.